SCM
ATRC icon

Soleus Capital Management’s AtriCure ATRC Stock Holding History

Soleus Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-392,195
Closed -$14M – 94
2023
Q4 		$14M Buy
392,195
+86,195
+28% +$3.21M 1.55% 20
2023
Q3 		$13.4M Buy
+306,000
New +$14.9M 1.24% 29

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Soleus Capital Management's ATRC Position: Q1 2024 in Review

Soleus Capital Management sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 392,195 shares — an estimated $14M sold.

Soleus Capital Management first reported a position in ATRC in Q3 2023 and held it in 2 quarters. The position peaked at $14M in Q4 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Soleus Capital Management reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Soleus Capital Management sold 392,195 AtriCure shares in Q1 2024, an estimated $14M.
  • Soleus Capital Management first reported a position in AtriCure in Q3 2023 and held it in 2 quarters.
  • Soleus Capital Management's AtriCure position peaked at $14M in Q4 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Soleus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.